Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
Business

Weight-Loss Drug Wegovy Cuts Heart Risk in New Study

Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link

Learning a Language May Stave Off Dementia, but Are Apps the Way to Go?
Business

Learning a Language May Stave Off Dementia, but Are Apps the Way to Go?

Language-learning software is seen to strengthen cognition and combat loneliness in older adults. Source link

Pfizer’s Covid Boost Crashes to Earth
Business

Pfizer’s Covid Boost Crashes to Earth

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.

First Pill for Postpartum Depression Is Approved by FDA
Business

First Pill for Postpartum Depression Is Approved by FDA

The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial. Source link

‘How Do I Do That?’ The New Hires of 2023 Are Unprepared for Work
Business

‘How Do I Do That?’ The New Hires of 2023 Are Unprepared for Work

Listen to article (2 minutes) Roman Devengenzo was consulting for a robotics company in Silicon Valley last fall when he asked a newly minted mechanical

It Might Be Quitting Time for the Fed's Rate Hawks
Business

It Might Be Quitting Time for the Fed's Rate Hawks

Workers in some sectors are still leaving jobs at a higher rate than before the pandemic in a sign that the job-market realignment continues. Source

Yellow's Shutdown Could Cost Taxpayers Money
Business

Yellow's Shutdown Could Cost Taxpayers Money

Whether the federal government recovers the money it lent Yellow at the height of the pandemic would likely depend on how much Yellow raises by

Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
Business

Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease

Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that

Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
Business

Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall

The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link